Instructions for Authors

Canadian Journal of Medicine is an open access publication, providing authors with continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. The Canadian Journal of Medicine review process emphasizes the scientific, technical and ethical validity of submissions. Novelty or potential for impact are not considered during the manuscript’s evaluation or adjudication.

 

How to Submit

The submissions can be made by using one of the following ways:

1- The manuscript and  related files can be submitted by  online submission system using the following link:

https://ijol.cikd.ca/contacts?_action=loginForm

2- The manuscript and  related files can be directly sent to the following email address:

wilkinson@cikd.ca

 

Style and language

For editors and reviewers to accurately assess the work presented in your manuscript you need to ensure the English language is of sufficient quality to be understood.

Manuscript Preparation Necessary

Research article or original article

  •   Review
  •   Case report
  •   Short  report or communication

Quick points:

  •  Use double line spacing
  •  Include line and page numbering
  •  Do not use page breaks in your manuscript
  •  Manuscript. A single word processing file, including title, authors, abstract, main text, references and figure legends
  •  Figure(s).Optional
  •  Table(s).Optional

 

Letters to the Editor

Letters can be responses to articles or other letters published in the journal or brief comments about issues of importance in general medicine. Letters submitted to the Editor should contain a brief and thoughtful analysis of an original article. Please note that publication is not guaranteed. References, if appropriate, can be provided. Letters to the Editor should be no longer than 500 words.

 

Plagiarism

Plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic)

Canadian Journal of Medicine is a member of Cross Check by Cross Ref and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com.Plagiarism is scientific misconduct and will be addressed as such. When plagiarism is detected at any time before publication, the Canadian Journal of Medicine editorial office will take appropriate action as directed by the standards set forth by the Committee on Publication Ethics (COPE). For additional information, please visit http://www.publicationethics.org.

Cover letter

A cover letter that includes the following information, as well as any additional information requested in the instructions

  •   An explanation of why your manuscript should be published in Diagnostic Pathology
  •   An explanation of any issues relating to journal policies
  •   A declaration of any potential competing interests
  •   Confirmation that all authors have approved the manuscript for submission
  •   If you are submitting a manuscript to a particular special issue, please refer to its specific name in your covering letter

 

Authorship

Canadian Journal of Medicine adheres to the Authorship Requirements as defined by the International

Committee of Medical Journal Editors (ICMJE). For more information, please visit http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html.

Changes to Authorship

Canadian Journal of Medicine considers the final author list to be complete at the time of the first revision submission. Please be sure to check that all authors are properly listed on the revision submission, this includes the spelling of an author’s name, their designated degrees, and order of authors listed. Canadian Journal of Medicine has a strict policy on changes to authorship after acceptance of the article and will only consider changes in the most extraordinary situations once the article is accepted.

Formatting Style

  •  Text should be 1.5-spaced.
  •  Typeface should be Times/Times New Roman or similar serif typeface.
  •  Do not use a sans serif typeface (eg, Arial/Helvetica).
  •  Body text size should be no smaller than 10 pt and no larger than 12 pt.
  • To assist reviewers, please include page numbers in the manuscript file.

Title

Manuscripts must be submitted with both a full title and a short title, which will appear at the top of the PDF upon publication if accepted. Only the full title should be included in the manuscript file; the short title will be entered during the online submission process. The full title should be specific, descriptive, concise, and c Authors and Affiliation

All author names should be listed in the following order:

  •   First names (or initials, if used),
  •   Middle names (or initials, if used)
  •  Last names (surname, family name)

Each author should list an associated department, university, or organizational affiliation and its location, including city, state/province (if applicable), and country.

One author should be designated as the corresponding author, and his or her email address should be included on the manuscript cover page. This information will be published with the article if accepted.

For questions regarding authorship requirements, please consult the ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical web page at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html.

Abstract

Abstracts are not required for Review Articles ,Editorials, Commentaries, Communications, or Letters to the Editor

 

Structured abstracts are required for Original, short report and case report Articles and must have three to four specified subtitles:

Research or original articles and short reports

A structured abstract should be no more than 300words. The abstract must include the following separate sections:

  •   Background: the context and purpose of the study
  •   Methods: how the study was performed and statistical tests used
  •   Results: the main findings
  •   Conclusions: brief summary and potential implications

 

Abstract

Case report

The Abstract should not exceed 300 words. Please minimize the use of abbreviations and do not cite references in the abstract. The abstract must include the following separate sections:

  • Background: why the case should be reported and its novelty
  • Case presentation: a brief description of the patient’s clinical and demographic details, the diagnosis, any interventions and the outcomes
  • Conclusions: a brief summary of the clinical impact or potential implications of the case report

Keywords

Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.

The main body for research or original articles and short reports including:

Introduction/Materials and Methods/Results/Discussion and Conclusions

The overall structure of your manuscript text should be in compliance with the corresponding reporting guideline

The main body for case reports including:

Background

The Background section should explain the background to the case report or study, its aims, a summary of the existing literature.

Case presentation

This section should include a description of the patient’s relevant demographic details, medical history, symptoms and signs, treatment or intervention, outcomes and any other significant details.

Discussion and Conclusions

This should discuss the relevant existing literature and should state clearly the main conclusions, including an explanation of their relevance or importance to the field.

Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Authors should also disclose whether they had any writing assistance

Ethics approval

Manuscripts reporting studies involving human participants, human data or human tissue must:

  • include a statement on ethics approval and consent (even where the need for approval was waived)
  • include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

Studies involving animals must include a statement on ethics approval.

If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.

Conflict of interests

All financial and non-financial competing interests must be declared in this section.

Please use the authors initials to refer to each authors' competing interests in this section.

If you do not have any competing interests, please state "The authors declare that they have no conflict of interests" in this section.

 

References

Examples of the Vancouver reference style are shown below.

Example reference style:

Article within a journal

Smith JJ. The world of science. Am J Sci. 1999;36:234-5.

Article within a journal (no page numbers)

 Text: Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

List: Number the references (numbers in square brackets) in the list in the order in which they appear in the text.

Examples:
Reference to a journal publication:

[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2010;163:51–9

Reference to a journal publication with an article number:

[2] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. Heliyon. 2018;19:e00205

Reference to a book:

[3] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.

Reference to a chapter in an edited book:


[4] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304.

Reference to a website:

[5] Cancer Research UK. Cancer statistics reports for the UK, http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/; 2003 [accessed 13 March 2003].

Reference to a dataset: [dataset]

[6] Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015.https://doi.org/10.17632/xwj98nb39r.1.
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6 should be listed followed by 'et al.' For further details you are referred to 'Uniform Requirements for Manuscripts submitted to Biomedical Journals' (J Am Med Assoc 1997;277:927–34) (see also Samples of Formatted References).

Tables

  •  Create tables using the table formatting and editing feature of your word processing software. Do not use Excel or comparable spreadsheet programs. Tables should be self-explanatory and should supplement, rather than duplicate, the material in the text.
  •  Tables are text-only items. Do not embed images within the table file.
  •   Each table file should include the table title, appropriate column heads, and any legends
  •   Do not embed tables within the manuscript file.
  •   Tables are numbered with arabic numerals (1, 2, 3, etc.) when there is more than one. Do not use roman numerals.
  •   Cite tables consecutively in the manuscript, and number them in the order in which they are discussed.
  •   Abbreviations are not permitted in table titles. Any abbreviation(s) used in the body of the table, including dashes, must be defined in a footnote to the table, listed in reading order.

Figures

  •   File formats appropriate for figures: TIFF, EPS, or MS Office (DOC, PPT, XLS) files.  Figures are numbered with arabic numerals (1, 2, 3, etc.) when there is more than one.
  •   Each file should be saved as the appropriate figure number (eg, Figure 1.tif). Do not include the author name in figure file name.
  •  Composite figures may be either submitted as one single print-quality image that is neatly labeled with uppercase letters using Arial/Helvetica bold font or submitted as separate panels (without labels), eg, Figure 1A.tif, Figure 1B.tif, to be combined during production if accepted for publication

Figure Legends

Legends for all figures should be brief and specific, and should appear on a separate page at the end of the manuscript document, following the list of references. Legends should indicate the figure number and must be numbered correctly.

Supplemental Content

Authors may submit supplemental digital content to enhance their article’s text. Supplemental digital content may include text documents like questionnaires, graphs, tables, figures, and videos. Supplemental digital content will not appear in the article itself but will appear online, accessible by a URL embedded in the article. Supplemental digital content files are not copy edited; they will be presented digitally as submitted. Supplemental content should include a sequential number if submitting more than one (1, 2, 3, etc.). Cite all supplemental digital content consecutively in the text

Accepted Manuscripts

Page Proofs / Electronic Proofs

Authors will receive notification via email that the PDF (portable document format) proofs of their article are available. Authors are urged to carefully examine the proofs, correct any inadequacies or inaccuracies, and answer all queries. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. Rewriting sections of text, adapting tables and figures, and/or adding/subtracting references are not permitted at this point in the process. Within 48 hours, corrections or approval should be sent to the Production Editor; a message summarizing the corrections may be sent by email

Editorial Office Contact

Email: wilkinson@cikd.ca